Monthly E-newsletter - October 2019
Festival Biologics 2019
Newsletter on Pharma advancement
Pharma Advancment news letter subscribe Advertise with us
Oct 10, 2019Ι Volume 10 I Pharma Advancement E-newsletter
  Pharma Advancement on LinkedIn Pharma Advancement on Facebook
Latest Updates
Thailand LAB INTERNATIONAL and Bio Investment Asia 2019
Constellation Pharmaceuticals Advances CPI-0209 into Clinical Trials, Expanding its EZH2 Franchise
Constellation Pharmaceuticals announced that the Company has dosed the first patient in a Phase 1/2 clinical trial of CPI-0209.CPI-0209 is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target...
Novo Nordisk and bluebird bio Enter 3-Year Gene Therapy Collaboration Pact
Pfizer and Flatiron Health
Amgen declares positive results for 2 Phase 3 BLINCYTO studies
Air France KLM Martinair Cargo
NSF International Acquires Majority Interest in Amarex CRO
Cryoport Introduces Cell Gene Industrys First Dedicated Shipper for Advanced Therapies
CHMP Recommends Approval of Dupixent for Severe Chronic Rhinosinusitis with Nasal Polyposis
Advertise in Our Next Issue - Contact
iOmx Therapeutics
Novartis ligelizumab outperforms Roche’s Xolair in chronic urticaria clearance

Novartis has pulled back the curtain on new Phase 2b data for its IgE/FceR1 pathway-blocking drug ligelizumab, showing that the therapy outperformed Roche’s Xolair in key metrics...

View All Press Releases
Popular Events

Festival of Biologics
2019-10-15 - 2019-10-16
Congress Centre , Basel, Switzerland

The Future Healthcare Turkey 2019
2019-10-24 - 2019-10-25
Istanbul, Turkey

SWOP – Shanghai World of Packaging
2019-11-25 - 2019-11-28
Shanghai New International Expo Centre

Stem Cell Community Day 2019
2019-11-21 - 2019-11-21
The Oitavos Hotel in Cascais , Lisbon , Portugal


Editorial Inquiries

Advertising Inquiries

Untitled Document